Experimental Therapeutics, a translational research department within the BC Cancer Agency, provides anticancer drug development capabilities which are focused on the critical need to rapidly establish the therapeutic value of emerging intervention strategies through validated assessments in preclinical models of cancer and in patients. (Program was previously called Advanced Therapeutics.)